|
PTMA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.837770E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.137170E-01 |
| Normal-vs-Stage2 |
3.727800E-02 |
| Normal-vs-Stage3 |
2.41779999999858E-05 |
| Normal-vs-Stage4 |
5.266400E-02 |
| Stage1-vs-Stage2 |
1.559820E-01 |
| Stage1-vs-Stage3 |
1.937810E-03 |
| Stage1-vs-Stage4 |
2.777800E-01 |
| Stage2-vs-Stage3 |
7.950400E-01 |
| Stage2-vs-Stage4 |
5.929000E-01 |
| Stage3-vs-Stage4 |
2.591000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.455400E-03 |
| Normal-vs-AfricanAmerican |
9.685600E-02 |
| Normal-vs-Asian |
6.733000E-01 |
| Caucasian-vs-AfricanAmerican |
6.477600E-01 |
| Caucasian-vs-Asian |
2.098600E-01 |
| AfricanAmerican-vs-Asian |
2.322000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.555800E-01 |
| Normal-vs-Female |
4.151800E-04 |
| Male-vs-Female |
1.356560E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.793800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.168710E-04 |
| Normal-vs-Age(61-80Yrs) |
1.302570E-03 |
| Normal-vs-Age(81-100Yrs) |
1.834990E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.982000E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.704180E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.858800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.933000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.499200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.211000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.444100E-02 |
| Classical-VS-Follicular |
6.121200E-01 |
| Classical-VS-Other |
6.585900E-02 |
| Classical-VS-Normal |
3.443600E-02 |
| Tall-VS-Follicular |
2.214600E-01 |
| Tall-VS-Other |
2.007800E-02 |
| Tall-VS-Normal |
5.601500E-03 |
| Follicular-VS-Other |
1.534790E-01 |
| Follicular-VS-Normal |
8.084100E-02 |
| Other-VS-Normal |
2.679600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.034300E-02 |
| Normal-vs-N1 |
9.538000E-01 |
| N0-vs-N1 |
1.263040E-01 |
|
|
